Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (28605)	5/24/2002 9:04:26 AM
From: arnold silver	Read Replies (2) \| Respond to of 29382

Ken,I bought this baby, looking for a turnaround. Howz it look to you? InKine Fills Distribution Channel: Strong Customer Demand For Visicol New Formulation BLUE BELL, Pa.--(BUSINESS WIRE)--May 23, 2002--InKine Pharmaceutical Company, Inc. (Nasdaq:INKP) today announced that orders have been filled for full distribution of Visicol to distributors and large drug store chains and that customer demand and gastroenerologist interest in the new formulation are strong. The Company's newly opened distribution center has to date shipped in excess of 40,000 bottles of the new formulation of Visicol to distributors and large drug store chains. The Company has received orders for an additional 50,000 bottles, which will enter the distribution channel over the next few months. Orders received to date for the new formulation represent product revenue to the Company in excess of $3 million. "Today's announcement marks not only the full distribution of the new and improved Visicol formulation, but also a milestone achievement in the development of our commercial operations," said Leonard S. Jacob, M.D., Ph.D., Chairman and CEO of InKine. "Customer orders for the new formulation and recent prescription data for the old formulation are strong and continue to grow. Gastroenterologist enthusiasm for the new formulation, evidenced at the recently completed Annual Digestive Disease Week (DDW) Conference in San Francisco, are encouraging," added Dr. Jacob. About InKine Pharmaceutical Arnie